Structure-brain exposure relationships

被引：555

作者：

Hitchcock, Stephen A. ^{[1
]}

Pennington, Lewis D. ^{[1
]}

机构：

[1] Amgen Inc, Chem Res & Discovery, Thousand Oaks, CA 91320 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2006年 / 49卷 / 26期

关键词：

D O I：

10.1021/jm060642i

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：7559 / 7583

页数：25

共 136 条

[31] The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model [J].

Doran, A ;

Obach, RS ;

Smith, BJ ;

Hosea, NA ;

Becker, S ;

Callegari, E ;

Chen, CP ;

Chen, X ;

Choo, E ;

Cianfrogna, J ;

Cox, LM ;

Gibbs, JP ;

Gibbs, MA ;

Hatch, H ;

Hop, CECA ;

Kasman, IN ;

LaPerle, J ;

Liu, JH ;

Liu, XR ;

Logman, M ;

Maclin, D ;

Nedza, FM ;

Nelson, F ;

Olson, E ;

Rahematpura, S ;

Raunig, D ;

Rogers, S ;

Schmidt, K ;

Spracklin, DK ;

Szewc, M ;

Troutman, M ;

Tseng, E ;

Tu, MH ;

Van Deusen, JW ;

Venkatakrishnan, K ;

Walens, G ;

Wang, EQ ;

Wong, D ;

Yasgar, AS ;

Zhang, CH .

DRUG METABOLISM AND DISPOSITION, 2005, 33 (01) :165-174

[32] In silico prediction models for blood-brain barrier permeation [J].

Ecker, GF ;

Noe, CR .

CURRENT MEDICINAL CHEMISTRY, 2004, 11 (12) :1617-1628

[33] Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds -: implications for pharmaccokinetics of selected substrates [J].

El Ela, AA ;

Härtter, S ;

Schmitt, U ;

Hiemke, C ;

Spahn-Langguth, H ;

Langguth, P .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (08) :967-975

[34]

El-Bacha RS, 1999, CELL MOL BIOL, V45, P15

[35] NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo [J].

Eriksen, JL ;

Sagi, SA ;

Smith, TE ;

Weggen, S ;

Das, P ;

McLendon, DC ;

Ozols, VV ;

Jessing, KW ;

Zavitz, KH ;

Koo, EH ;

Golde, TE .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) :440-449

[36] Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs [J].

Faasen, F ;

Vogel, G ;

Spanings, H ;

Vromans, H .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 263 (1-2) :113-122

[37] Assessment of blood-brain barrier penetration:: In silico, in vitro and in vivo [J].

Feng, MR .

CURRENT DRUG METABOLISM, 2002, 3 (06) :647-657

[38] Importance of P-glycoprotein at blood-tissue barriers [J].

Fromm, MF .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (08) :423-429

[39] Discovering drugs through biological transformation: Role of pharmacologically active metabolites in drug discovery [J].

Fura, A ;

Shu, YZ ;

Zhu, MS ;

Hanson, RL ;

Roongta, V ;

Humphreys, WG .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (18) :4339-4351

[40] In vitro models for the blood-brain barrier [J].

Garberg, P ;

Ball, M ;

Borg, N ;

Cecchelli, R ;

Fenart, L ;

Hurst, RD ;

Lindmark, T ;

Mabondzo, A ;

Nilsson, JE ;

Raub, TJ ;

Stanimirovic, D ;

Terasaki, T ;

Öberg, JO ;

Österberg, T .

TOXICOLOGY IN VITRO, 2005, 19 (03) :299-334

← 1 2 3 4 5 6 7 8 9 10 →